3 employees of Noida-based Marion Biotech arrested

Published On 2023-03-04 07:00 GMT   |   Update On 2023-03-04 11:50 GMT

New Delhi: The Noida Police on Friday arrested three employees of a Noida-based pharmaceutical firm whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, officials said.The arrests come after an FIR was lodged late Thursday night against five officials of Marion Biotech, including two of its directors, over a complaint by a drugs inspector of the...

Login or Register to read the full article

New Delhi: The Noida Police on Friday arrested three employees of a Noida-based pharmaceutical firm whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, officials said.

The arrests come after an FIR was lodged late Thursday night against five officials of Marion Biotech, including two of its directors, over a complaint by a drugs inspector of the Central Drugs Standard Control Organization (CDSCO), they said.
The central and Uttar Pradesh state drug authorities had checked samples of Marion Biotech's drugs and found 22 of them to be "not of standard quality" (adulterated and spurious), according to the complainant drug inspector.
"Three persons named in the FIR have been arrested, while the two directors of the company are at large. Those arrested are Tuhin Bhattacharya, Head Operation; Atul Rawat, Manufacturing Chemist; and Mool Singh, Analytical Chemist," Phase 3 police station in-charge Vijay Kumar told PTI.
Marion Biotech, which has its office in Sector 67 in Noida, had come under the scanner in December last year for its cough syrup Dok-1 that is suspected to have led to the death of 18 children who consumed it in Uzbekistan after which the CDSCO launched a probe into the matter.
Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News